EUVIMEDAvasta EUVIMED
Crossref

Imaging Biomarkers in Systemic Disease: Quantitative Radiology and Precision Medicine in Clinical Practice

Richard Adrian Vergara Trujillo, Joseph Rodríguez Sánchez, Milton Fernando Crespo Macias, Borely Josué Uribio Alemán, Juan Pablo Monroy Moreno, Jorge Angel Velasco Espinal, Alexa Fernanda Uriostegui Navarro, Alma Valeria Popoca García

International Science Journal · 2026-06-03 · 3 (1)

DOI: 10.64784/220 ↗

At a glance

Journal article in International Science Journal, published online on 2026-06-03. Written by Richard Adrian Vergara Trujillo and 7 co-authors.

AbstraktBibliograafilised andmedCiteRelated studies

Abstract (original language)

Imaging biomarkers have progressively transformed modern radiology by providing quantitative, functional, and molecular information capable of improving early disease detection, diagnostic precision, therapeutic monitoring, and clinical decision-making in systemic diseases. The present review aimed to analyze the current role of imaging biomarkers in oncology and internal medicine, emphasizing their contribution to precision medicine and multidisciplinary healthcare management. A structured documentary review was conducted using peer-reviewed scientific literature indexed in internationally recognized databases, including PubMed, Scopus, ScienceDirect, and SpringerLink. The analyzed evidence focused on advanced imaging modalities such as computed tomography, magnetic resonance imaging, positron emission tomography, hybrid imaging systems, radiomics, and artificial intelligence-assisted imaging analysis. The reviewed studies demonstrated that imaging biomarkers possess broad applicability in oncology, neurological disorders, cardiovascular diseases, inflammatory conditions, chronic hepatic disease, pulmonary pathology, and metabolic disorders. Functional and molecular imaging techniques showed particular relevance for evaluating metabolism, tissue perfusion, angiogenesis, fibrosis, inflammation, cellular density, and tumor heterogeneity. Radiomics and artificial intelligence were identified as emerging technologies capable of improving predictive analysis, treatment response assessment, and individualized therapeutic planning.

Cite

APA

Trujillo, R. A. V., Sánchez, J. R., Macias, M. F. C., Alemán, B. J. U., Moreno, J. P. M., Espinal, J. A. V., Navarro, A. F. U., & García, A. V. P. (2026). Imaging Biomarkers in Systemic Disease: Quantitative Radiology and Precision Medicine in Clinical Practice. International Science Journal, 3(1). https://doi.org/10.64784/220

Vancouver

Trujillo RAV, Sánchez JR, Macias MFC, Alemán BJU, Moreno JPM, Espinal JAV, et al. Imaging Biomarkers in Systemic Disease: Quantitative Radiology and Precision Medicine in Clinical Practice. International Science Journal. 2026;3(1). doi:10.64784/220

BibTeX
@article{Trujillo2026,
  author = {Trujillo, Richard Adrian Vergara and Sánchez, Joseph Rodríguez and Macias, Milton Fernando Crespo and Alemán, Borely Josué Uribio and Moreno, Juan Pablo Monroy and Espinal, Jorge Angel Velasco and Navarro, Alexa Fernanda Uriostegui and García, Alma Valeria Popoca},
  title = {Imaging Biomarkers in Systemic Disease: Quantitative Radiology and Precision Medicine in Clinical Practice},
  journal = {International Science Journal},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.64784/220}
}
Start for free →